AI for Blue Light Cystoscopy
Enhanced diagnosis of Bladder Cancer
DevelopmentCo-development partnership with Intelligent Scopes Corporation (Oct 2025)
Key Facts
Indication
Enhanced diagnosis of Bladder Cancer
Phase
Development
Status
Co-development partnership with Intelligent Scopes Corporation (Oct 2025)
Company
About Photocure
Photocure ASA, 'The Bladder Cancer Company,' is a commercial-stage biopharmaceutical firm dedicated to improving the diagnosis and management of bladder cancer through its photodynamic technology platform. Its approved product, Hexvix, enhances the accuracy of cystoscopy procedures, leading to better patient outcomes and reduced recurrence rates. The company is actively pursuing partnerships, AI integration, and new clinical data to solidify its position as a leader in urologic oncology diagnostics while maintaining a strong commitment to ESG principles.
View full company profile